@article{c93107b705bf4e6095b06b5b24892ea6,
title = "Points to consider: is there evidence to support BRCA1/2 and other inherited breast cancer genetic testing for all breast cancer patients? A statement of the American College of Medical Genetics and Genomics (ACMG)",
keywords = "BRCA1, BRCA2, breast cancer, genetic testing, multigene panels",
author = "{on behalf of the Professional Practice and Guidelines Committee} and Tuya Pal and Doreen Agnese and Mary Daly and {La Spada}, Albert and Jennifer Litton and Myra Wick and Susan Klugman and Esplin, {Edward D.} and Jarvik, {Gail P.}",
note = "Funding Information: J.L. has grant research support from Novartis, Medivation/Pfizer, Genentech, GSK, EMD-Serono, AstraZeneca, Medimmune; is on the Speakers Bureau for MedLearning, Physician{\textquoteright}s Education Resource, Prime Oncology, Medscape, Clinical Care Operations; has received honoraria from UpToDate; and has memberships on advisory committees or review panels, board memberships, etc. for AstraZeneca and Pfizer (both uncompensated). E.D.E. is an employee of Invitae and has stock and other ownership interests in Invitae. The other authors declare no conflicts of interest.",
year = "2020",
month = apr,
day = "1",
doi = "10.1038/s41436-019-0712-x",
language = "English (US)",
volume = "22",
pages = "681--685",
journal = "Genetics in Medicine",
issn = "1098-3600",
publisher = "Lippincott Williams and Wilkins",
number = "4",
}
